PCG
74
2
UNP
38
2
UNM
65
-7
MA
55
4
QCOM
45
2
XEL
37
-2
BMY
76
2
RIG
40
2
FFIV
47
-3
RCL
68
4
IR
58
3
MMM
56
2
HAL
50
2
PSX
37
2
ZBH
42
-2
TMO
60
4
ILMN
73
4
HSY
43
2
GD
62
5
CMA
70
5
PCG
74
2
UNP
38
2
UNM
65
-7
MA
55
4
QCOM
45
2
XEL
37
-2
BMY
76
2
RIG
40
2
FFIV
47
-3
RCL
68
4
IR
58
3
MMM
56
2
HAL
50
2
PSX
37
2
ZBH
42
-2
TMO
60
4
ILMN
73
4
HSY
43
2
GD
62
5
CMA
70
5
Financhill
Back

SPDR Portfolio Developed World ex-US ETF Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison

Buy
52

SPDW
SPDR Portfolio Developed World ex-US ETF

Last Price:
$44.79
Seasonality Move:
-0.85%
Sell
23

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:
$33.50
Seasonality Move:
-0.96%
Buy
52
SPDR Portfolio Developed World ex-US ETF (SPDW) is a Buy

Is SPDR Portfolio Developed World ex-US ETF a Buy, Sell or Hold?

  • The current SPDR Portfolio Developed World ex-US ETF [SPDW] share price is $44.78. The Score for SPDW is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • SPDW is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $33.50. The Score for RARE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SPDW Stock Price Chart

What is SPDR Portfolio Developed World ex-US ETF's stock price today?

  • The SPDR Portfolio Developed World ex-US ETF share price today is $44.78
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPDW is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical, Inc.'s stock price today?

  • The Ultragenyx Pharmaceutical, Inc. share price today is $33.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight buying pressure.

SPDW Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.38 Buy
Relative Strength Index (14 RSI): 61.18 Buy
Chaikin Money Flow: -1916493 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.04 - 44.58) Buy
Bollinger Bands (100): (41.69 - 43.97) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.24 Buy
Relative Strength Index (14 RSI): 45.54 Sell
Chaikin Money Flow: 579058 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.65 - 35.95) Sell
Bollinger Bands (100): (29.19 - 34.19) Buy

SPDW Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.59 Buy
20-day SMA: 44.04 Buy
50-day SMA: 43.63 Buy
200-day SMA: 40.7 Buy
8-day EMA: 23.59 Buy
20-day EMA: 11.55 Buy
50-day EMA: 5.03 Buy
200-day EMA: 1.32 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.82 Sell
20-day SMA: 34.8 Sell
50-day SMA: 33.74 Sell
200-day SMA: 33.57 Sell
8-day EMA: 17.59 Buy
20-day EMA: 8.61 Buy
50-day EMA: 3.75 Buy
200-day EMA: 0.98 Buy

SPDR Portfolio Developed World ex-US ETF Earnings Growth & SPDW Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

SPDR Portfolio Developed World ex-US ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):